Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze CRL stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CRL investment potential.

What is CRL stock price today?

Get real-time CRL stock price, historical data, and price charts on Financhill. Track CRL performance with our advanced analysis tools.

Is CRL a good investment?

Evaluate CRL investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CRL stock?

To buy CRL stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CRL?

View detailed market capitalization data and company valuation metrics for CRL on our comprehensive analysis page.

What is the P/E ratio of CRL?

Use our fundamental analysis tools to view CRL P/E ratio and compare valuation metrics with industry peers.

What are CRL earnings?

View CRL earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Charles River Laboratories International, Inc. Stock Predictions

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

CRL
Charles River Laboratories International, Inc.

Last Price:

$196.99

Seasonality Move:

5.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Share Price Moved. Momentum Hasn't Slowed.

Charles River Laboratories International, Inc. Stock Forecast

Over the next 52 weeks, Charles River Laboratories International, Inc. has on average historically risen by 14.1% based on the past 25 years of stock performance.
Charles River Laboratories International, Inc. has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Is Charles River Laboratories International, Inc. Stock Undervalued?

The current Charles River Laboratories International, Inc. [CRL] share price is $197.06. The Score for CRL is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Charles River Laboratories International, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Charles River Laboratories International, Inc. has on average historically risen by 14.1% based on the past 25 years of stock performance.

Charles River Laboratories International, Inc. Stock Rating

Buy

Charles River Laboratories International, Inc. (CRL) is a Buy

Is Charles River Laboratories International, Inc. overpriced?

Charles River Laboratories International, Inc. has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Charles River Laboratories International, Inc. Stock Price History

Is CRL stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NYSE

Country:

United States

Industry:

Life Sciences Tools & Services

Sector:

Health Care

Type:

stock

Website:

criver.com

52-Week Data

52-Week High:

200.58

52-Week Low:

91.86

Prediction Charts

Market Cap:

9.7B

Price in USD:

197.06

Volume:

1.2M

Beta:

1.00

Technical Analysis

SMA50:

179.56

SMA100:

169.65

SMA200:

157.32

52-Wk Change:

8.19%

Stock Predictions

Is Charles River Laboratories International, Inc. stock public?

Yes, Charles River Laboratories International, Inc. is a publicly traded company.
What is the Charles River Laboratories International, Inc. stock quote today?

The Charles River Laboratories International, Inc. stock price is 197.06 USD today.
How to buy Charles River Laboratories International, Inc. stock online?

You can buy Charles River Laboratories International, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-2	173.99	174.76	177.01	172.95
Dec-3	180.91	184.67	185.93	180.00
Dec-4	186.61	184.04	186.72	176.37
Dec-5	185.01	184.31	185.90	182.71
Dec-8	184.39	187.12	189.15	183.43
Dec-9	186.80	185.99	191.34	185.93
Dec-10	187.59	194.85	195.06	186.10
Dec-11	194.93	194.43	196.38	192.38
Dec-12	194.37	193.03	195.51	192.09
Dec-15	197.08	198.15	200.58	195.10
Dec-16	197.31	195.22	198.32	194.50
Dec-17	194.56	195.98	198.95	194.56
Dec-18	197.32	193.85	199.93	193.63
Dec-19	193.46	197.06	198.34	191.89

Charles River Laboratories International, Inc. Earnings

Charles River Laboratories International, Inc. Earnings Report: Per Share Charles River Laboratories International, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Charles River Laboratories International, Inc. Forecast Revenue Growth

Charles River Laboratories International, Inc. Stock Analysis: Historical quarterly revenues per share for Charles River Laboratories International, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.70 per share.

* Charles River Laboratories International, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.